Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Research and development

Litigation settlement gain

Restructuring and other charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Align Technology

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Align Technology reports Q4 growth, eyes tech advancements for 2023

Align Technology's Q4 performance showed revenue growth in Systems and Services but challenges in Clear Aligner volumes, particularly in China.
The company is focusing on technology advancements, digital subscriptions, and margin improvement for 2023.
Investments in R&D for digital orthodontics and subscription programs present opportunities for future growth.
Despite challenges in China, Align remains optimistic about stability and growth in other regions.

Align Technology beats Q1 revenue expectations, eyes Q2 growth

Align Technology's Q1 performance exceeded expectations with revenue growth.
Stable Clear Aligner business and focus on teen market are strengths.
Challenges include increased expenses and uncertainty in margins.
Opportunities lie in expected volume and ASP increases in Q2.

Align Technology surpasses Q2 expectations, eyes international growth opportunities

Align Technology delivered strong Q2 results, driven by revenue growth in Clear Aligner and Systems and Services segments, with a focus on innovation and strategic initiatives.
The company's performance in international markets, particularly EMEA and APAC, showcased significant growth in teen cases and adoption of the DSP program.
While facing challenges in the teen market and competitive landscape, Align Technology remains optimistic about its long-term growth prospects and market positioning.
Opportunities for Align include continued innovation, market expansion, and investor engagement through strategic initiatives and product differentiation.

Align Technology reports Q3 revenue growth amidst macro challenges

Align Technology navigated challenges in Q3 with revenue growth driven by clear aligner shipments to younger patients and increased services revenue.
Despite lower Q3 demand, the company remains optimistic for 2024 revenue growth through new technologies and digital orthodontics adoption.
Strategic investments in R&D, cost management, and consumer advertising position Align Technology for future growth and margin improvement.

Align Technology surpasses Q4 expectations, eyes innovation for growth

Align Technology delivered strong financial performance in Q4 2023, with robust revenue growth and effective cost management.
The company's focus on innovation, strategic partnerships, and market expansion positions it well for future growth.
While facing challenges such as regulatory approvals and cash flow fluctuations, Align Technology has opportunities in market expansion and cost-saving initiatives.
Overall, Align Technology's performance, strengths, and strategic outlook indicate a positive trajectory for sustainable growth and profitability.

Align Technology posts solid Q1 earnings, eyes growth opportunities

Align Technology's Q1 performance reflects revenue growth and strategic investments in innovation and market expansion.
While facing challenges in operating expenses and margin decline, the company's strengths lie in product innovation and brand visibility.
Opportunities in new market expansion, targeting younger patients, and operational investments set the stage for future growth and profitability.

Align Technology posts solid Q2 results, eyes market expansion

Align Technology delivered strong financial performance in Q2, driven by revenue growth, margin expansion, and increasing adoption of its innovative solutions.
The company's focus on product innovation, digital tools, and marketing initiatives has bolstered its market position and customer engagement.
While facing challenges in a competitive landscape and regulatory processes, Align Technology remains well-positioned to capitalize on opportunities in the orthodontic market.
Strategic initiatives to drive growth, enhance operational efficiency, and expand market reach are key priorities for sustaining momentum and profitability.

Align Technology reports mixed Q3 results, eyes international growth

Align Technology's Q3 '24 showcased mixed results but highlighted growth opportunities in international markets and new product innovations.
Despite challenges in the U.S. market, the company's strategic focus on operational efficiency and digital innovation positions it for future success.
Investments in expansion and supporting doctor customers signal a commitment to driving growth and profitability in the long term.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Nasdaq lagged the rest of the market but could still finish out of the red.

Nasdaq Fights for Gains Tuesday; Has Align Finally Straightened Itself Out?

SmileDirectClub

In the 3-D printed teeth aligner business, which of these innovative health care companies has the edge, and which is the better investment?

Better Buy: SmileDirectClub vs. Align Technology

Align Technology's (ALGN) new virtual solutions ensure continuity of care amid pandemic.

Align Technology's Rollouts Aid Amid Procedural Deferrals

The stock has recovered from March's steep sell-offs and is now roughly back to where it began the year.

Why Align Technology Climbed 11.7% Last Month

AmerisourceBergen

Becton, Dickinson and Co.

Cardinal Health

Cooper Companies

Henry Schein

Labcorp Holdings Inc

McKesson

Patterson Companies

DENTSPLY SIRONA

Near-Term Outlook Bleak for Medical Dental Supplies Industry

Support for Program Underscores Align Technology’s Commitment to Advancing Health Solutions and Improving the Lives of Patients in the Asia Pacific Region Support for Program Underscores Align Technology’s Commitment to Advancing Health Solutions and Improving the Lives of Patients in the Asia Pacific Region

Align Technology Announces Partnership With MedTech Innovator Asia Pacific, Industry’s Leading Nonprofit Startup Accelerator

A once high-growth orthodontics equipment company is now in trouble. Should investors buy the dip?

Is Align Technology Stock a Buy?

Align Technology shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81.
The post Stocks To Watch: Align Technology Sees RS Rating Rise To 81 appeared first on Investor's Business Daily.

Stocks To Watch: Align Technology Sees RS Rating Rise To 81

T. Rowe Price Group

Ask some average investors how to identify a company that’s doing well. They will probably reply, “Good earnings growth and a rising stock price.

T. Rowe Price and Align Technology Show High Profit, Low Debt

With the economy improving on paper, ALGN stock – which depends on a strong consumer base willing to pay for pricey orthodontic procedures – is initially appealing. However, investors should look at the fine print.

Align Technology Has a Fundamental Gap

Intuitive Surgical

Masimo

Wall Street is looking forward to a return to normalcy in the healthcare sector.

Why These 3 Top Medical Tech Companies Rose More Than 12% in May

DraftKings

Livongo Health Inc

May was a winner for these three stocks. The month ahead may be even bigger.

3 Hot Stocks to Buy in June

eBay

Lululemon Athletica

MercadoLibre

Invesco QQQ

Tesla

The Nasdaq 100 index hit an all-time high in intraday trading on June 4, becoming the first major U.S. index to reach record highs after coronavirus plunge.

Nasdaq 100 Hits New Highs: 5 Best Stocks in the ETF

NetEase

Modest gains for the market made these two stocks stand out.

Nasdaq Today: Why NetEase and Align Technology Led Stocks Higher

Stocks I Bought On The Dip: Align Technology

The maker of Invisalign aligners had a tough first quarter because of the COVID-19 pandemic, but the company is poised for a breakout.

Why Align Technology Remains a Good Investment Opportunity

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?

Align Technology (ALGN) Up 16% Since Last Earnings Report: Can It Continue?

Align Technology shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
The post IBD Rating Upgrades: Align Technology Flashes Improved Relative Price Strength appeared first on Investor's Business Daily.

IBD Rating Upgrades: Align Technology Flashes Improved Relative Price Strength

DexCom

These are the health care stocks with the best value, fastest growth, and most momentum for June.

Top Health Care Stocks for June 2020

HCA Healthcare

HealthEquity

It was a pleasant start to the trading week.

Why Align Technology, HCA Healthcare, and HealthEquity Shares Soared Today

SAN JOSE, Calif. and LONDON, May  14, 2020  (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) today introduced the latest version of its proprietary ClinCheck treatment planning software at the Invisalign Scientific Symposium, a fully digital event for Invisalign-trained orthodontists. ClinCheck software provides doctors with a 3D model of planned tooth movements throughout the Invisalign treatment. ClinCheck Pro 6.0 moves Invisalign digital treatment planning to the cloud, making its robust ClinCheck treatment planning tools and features available to doctors anytime, anywhere, on any laptop, personal computer or tablet. The release includes the new ClinCheck “In-Face” Visualization tool, an enhanced doctor-facing digital clinical tool that combines a photo of the patient’s face with their 3D Invisalign treatment plan, creating a personalized view of how their new smile could look.

Align Technology Expands Digital Platform With Cloud-Based ClinCheck™ Pro 6.0 and ClinCheck "In-Face" Visualization for Invisalign Treatment

SAN JOSE, Calif., May  13, 2020  (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) today announced that due to circumstances related to the COVID-19 pandemic and to prioritize the health and well-being of our stockholders, employees, officers, directors and their families, the time and location of the Company’s 2020 Annual Meeting of Stockholders (including any adjournments or postponements, the “Annual Meeting”) has been changed to 1:00 p.m. Pacific Daylight Time and the location has been changed to a virtual-only format.

Align Technology Announces That Its 2020 Annual Meeting Of Stockholders Will Be Held At 1 P.M. Pacific Daylight Time On May 20, 2020 In A Virtual-Only Format

The stock price of Align Technology, a manufacturer of digital scanners and aligners used in orthodontics, has seen its stock price decline by about close to 25% year-to-date.However, by comparing the trend in Align’s stock over recent months with its trajectory during and after the Great Recession.

Align Technology’s Stock Is Beaten Down, But A Strong Recovery May Be Imminent

The company benefited from the broader market's gains, as well as signs that the economy would begin to reopen.

Why Align Technology Jumped 24% in April

Invisalign® Virtual Appointment and Invisalign® Virtual Care represent the next level in practice and care transformation, enabling doctors to manage a range of practice services even when they are not in the same physical location as their patients

News for Align Technology Stock (ALGN)